Marc Scheineson comments on what the Food and Drug Administration’s emergency use authorization update for COVID-19 drug Paxlovid could mean for other therapies.
In the News
July 7, 2022
The Pink Sheet | Could Pharmacist Prescribing Grow in Wake of Paxlovid Experience?
Media Contact